10th June 2014, Dr Maggie Curnutte on “The Next Generation Sequencing Industry: A Critique of the Policy-Lag Narrative”

When: Tuesday June 10th,  4:30 – 5:30 pm

Where: D12 East Wing King’s Building, King’s College Strand Campus

Dr Maggie Curnutte

Dr Maggie Curnutte

Dr Maggie Curnutte, Postdoctoral Fellow, Center for Medical Ethics & Health Policy, Baylor College of Medicine, Houston. Maggie will talk about “The Next Generation Sequencing Industry: A Critique of the Policy-Lag Narrative”


The next generation sequencing (NGS) industry is rapidly evolving and health care providers predict that NGS technologies will increasingly improve clinical care. Private industry is playing an important role as the cost of sequencing whole genomes declines and new platforms emerge to integrate and interpret NGS-generated data. The Food and Drug Administration and National Institutes of Health have publicly voiced their support for this industry and see it as integral to the future of personalized medicine. Key industry stakeholders, however, feel that policy is lagging behind NGS innovation and worry that future regulation will be too burdensome and slow progress. Much has been written to critique this policy-lag narrative, as it sets up a dynamic in which regulation is viewed as inhibiting progress. This stance also fails to consider that regulation is often advantageous to industry as a means to establish credibility, and woven into business practices as new technologies emerge. This paper draws on material from semi-structured interviews with NGS industry leaders (n=20) and comprehensive web-based analysis of NGS companies (n=96) to articulate three main points that counter the policy-lag narrative: 1) Companies are already working with existing genetic testing regulatory frameworks, 2) developing their services in response to a dynamic regulatory climate, and 3) demonstrating some forms of self-regulation. I want to draw attention to these three counterpoints, because the policy-lag narrative serves to limit the space for regulation and democratic control of the innovation pipeline.

If you are interested in attending this seminar email Dr Silvia Camporesi: silvia.camporesiATkcl.ac.uk

This entry was posted in Ethnography, Genomics, Science & Technology Studies, Sociology and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s